4/16
02:07 am
cpix
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
4/8
02:05 am
cpix
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Neutral
Report
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
4/2
04:17 pm
cpix
NEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE ACROSS PATIENT POPULATIONS [Yahoo! Finance]
Low
Report
NEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE ACROSS PATIENT POPULATIONS [Yahoo! Finance]
4/2
04:05 pm
cpix
NEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE ACROSS PATIENT POPULATIONS
Low
Report
NEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE ACROSS PATIENT POPULATIONS
3/31
02:07 am
cpix
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Neutral
Report
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
3/23
02:07 am
cpix
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Medium
Report
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
3/19
10:25 am
cpix
Methotrexate Drug Demand Soaring Due to Chronic Disease Burden and Biosimilar Adoption - Market to Reach US$ 1.058 Billion by 2034 [Yahoo! Finance]
Medium
Report
Methotrexate Drug Demand Soaring Due to Chronic Disease Burden and Biosimilar Adoption - Market to Reach US$ 1.058 Billion by 2034 [Yahoo! Finance]
3/15
02:21 am
cpix
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Neutral
Report
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
3/26
08:34 pm
cpix
Form 4 CUMBERLAND PHARMACEUTICA For: Mar 25 Filed by: Krogulski Kenneth
Medium
Report
Form 4 CUMBERLAND PHARMACEUTICA For: Mar 25 Filed by: Krogulski Kenneth
3/26
08:33 pm
cpix
Form 4 CUMBERLAND PHARMACEUTICA For: Mar 25 Filed by: Jones James
Medium
Report
Form 4 CUMBERLAND PHARMACEUTICA For: Mar 25 Filed by: Jones James
3/26
08:32 pm
cpix
Form 4 CUMBERLAND PHARMACEUTICA For: Mar 25 Filed by: Galante Joseph C
Medium
Report
Form 4 CUMBERLAND PHARMACEUTICA For: Mar 25 Filed by: Galante Joseph C
3/26
08:31 pm
cpix
Form 4 CUMBERLAND PHARMACEUTICA For: Mar 25 Filed by: Young Caroline
Medium
Report
Form 4 CUMBERLAND PHARMACEUTICA For: Mar 25 Filed by: Young Caroline
3/26
08:30 pm
cpix
Form 4 CUMBERLAND PHARMACEUTICA For: Mar 25 Filed by: Brown Martin S JR
Medium
Report
Form 4 CUMBERLAND PHARMACEUTICA For: Mar 25 Filed by: Brown Martin S JR
3/26
08:29 pm
cpix
Form 4 CUMBERLAND PHARMACEUTICA For: Mar 23 Filed by: KAZIMI A J
Medium
Report
Form 4 CUMBERLAND PHARMACEUTICA For: Mar 23 Filed by: KAZIMI A J
3/26
08:26 pm
cpix
Form 4 CUMBERLAND PHARMACEUTICA For: Mar 23 Filed by: Herman James L
Medium
Report
Form 4 CUMBERLAND PHARMACEUTICA For: Mar 23 Filed by: Herman James L
3/26
08:25 pm
cpix
Form 4 CUMBERLAND PHARMACEUTICA For: Mar 23 Filed by: Bitterman Chris T.
Medium
Report
Form 4 CUMBERLAND PHARMACEUTICA For: Mar 23 Filed by: Bitterman Chris T.
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register